InspireMD, Inc. (NSPR)
USD 2.69
(3.07%)
USD 2.69
(3.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -20.91 Million USD | -10.38% |
| 2022 | -18.52 Million USD | -28.57% |
| 2021 | -14.55 Million USD | -40.22% |
| 2020 | -10.38 Million USD | -5.75% |
| 2019 | -9.85 Million USD | -28.97% |
| 2018 | -7.45 Million USD | 7.54% |
| 2017 | -8.05 Million USD | -7.64% |
| 2016 | -7.45 Million USD | 38.92% |
| 2015 | -14.24 Million USD | 47.16% |
| 2014 | -23.43 Million USD | -59.42% |
| 2013 | -14.86 Million USD | 8.38% |
| 2012 | -16.22 Million USD | -17.73% |
| 2011 | -13.34 Million USD | -197448.74% |
| 2010 | -3.17 Million USD | -82.38% |
| 2009 | -2.36 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -8.19 Million USD | -11.56% |
| 2024 Q1 | -7.34 Million USD | -27.81% |
| 2023 Q1 | -4.32 Million USD | 12.36% |
| 2023 Q3 | -5.63 Million USD | -7.27% |
| 2023 Q4 | -5.74 Million USD | -1.92% |
| 2023 FY | - USD | -10.38% |
| 2023 Q2 | -5.25 Million USD | -21.52% |
| 2022 Q4 | -4.93 Million USD | -8.25% |
| 2022 Q1 | -4.44 Million USD | -14.24% |
| 2022 FY | - USD | -28.57% |
| 2022 Q2 | -4.68 Million USD | -5.31% |
| 2022 Q3 | -4.56 Million USD | 2.58% |
| 2021 Q2 | -3.4 Million USD | -4.41% |
| 2021 Q4 | -3.89 Million USD | 2.58% |
| 2021 FY | - USD | -40.22% |
| 2021 Q1 | -3.26 Million USD | 12.24% |
| 2021 Q3 | -3.99 Million USD | -17.23% |
| 2020 Q3 | -2.16 Million USD | 10.29% |
| 2020 FY | - USD | -5.75% |
| 2020 Q1 | -1.97 Million USD | 21.39% |
| 2020 Q2 | -2.4 Million USD | -22.28% |
| 2020 Q4 | -3.71 Million USD | -72.05% |
| 2019 Q3 | -1.95 Million USD | 10.4% |
| 2019 Q2 | -2.18 Million USD | 30.26% |
| 2019 Q1 | -3.13 Million USD | -41.89% |
| 2019 FY | - USD | -28.97% |
| 2019 Q4 | -2.5 Million USD | -28.12% |
| 2018 Q2 | -589 Thousand USD | 74.91% |
| 2018 Q4 | -2.2 Million USD | -11.7% |
| 2018 Q3 | -1.97 Million USD | -235.31% |
| 2018 FY | - USD | 7.54% |
| 2018 Q1 | -2.34 Million USD | -61.93% |
| 2017 Q3 | -2.04 Million USD | 9.28% |
| 2017 Q4 | -1.45 Million USD | 29.03% |
| 2017 FY | - USD | -7.64% |
| 2017 Q1 | -2.39 Million USD | -14.47% |
| 2017 Q2 | -2.25 Million USD | 6.05% |
| 2016 Q4 | -2.09 Million USD | -18.84% |
| 2016 FY | - USD | 38.92% |
| 2016 Q1 | -2.38 Million USD | 7.53% |
| 2016 Q3 | -1.76 Million USD | -0.97% |
| 2016 Q2 | -1.74 Million USD | 26.71% |
| 2015 FY | - USD | 47.16% |
| 2015 Q3 | -2.91 Million USD | 17.38% |
| 2015 Q4 | -2.57 Million USD | 11.66% |
| 2015 Q2 | -3.52 Million USD | 18.07% |
| 2015 Q1 | -4.3 Million USD | 3.17% |
| 2014 Q2 | -7.23 Million USD | -30.6% |
| 2014 Q3 | -6.37 Million USD | 11.9% |
| 2014 FY | - USD | -59.42% |
| 2014 Q1 | -5.54 Million USD | 0.0% |
| 2014 Q4 | -4.44 Million USD | 30.23% |
| 2013 Q2 | -4.15 Million USD | -31.42% |
| 2013 Q1 | -3.16 Million USD | 26.6% |
| 2013 FY | - USD | 8.38% |
| 2013 Q4 | - USD | 100.0% |
| 2013 Q3 | -3.81 Million USD | 8.14% |
| 2012 Q2 | -3.59 Million USD | -16.33% |
| 2012 Q1 | -3.09 Million USD | 62.93% |
| 2012 FY | - USD | -17.73% |
| 2012 Q4 | -4.3 Million USD | -32.58% |
| 2012 Q3 | -3.24 Million USD | 9.73% |
| 2011 Q1 | -1.14 Million USD | -44023.31% |
| 2011 FY | - USD | -197448.74% |
| 2011 Q4 | -8.34 Million USD | -290.5% |
| 2011 Q3 | -2.13 Million USD | 1.07% |
| 2011 Q2 | -2.15 Million USD | -88.56% |
| 2010 Q4 | -2595.00 USD | -151.9% |
| 2010 FY | - USD | -82.38% |
| 2010 Q3 | 5000.00 USD | 307.04% |
| 2010 Q2 | -2415.00 USD | 36.21% |
| 2010 Q1 | -3786.00 USD | -41.27% |
| 2009 Q1 | -100.00 USD | 0.0% |
| 2009 Q2 | -225.00 USD | -125.0% |
| 2009 Q3 | 6595.00 USD | 3031.11% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | -2680.00 USD | -140.64% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -55.046% |
| Cerus Corporation | -26.53 Million USD | 21.198% |
| OrthoPediatrics Corp. | -8.38 Million USD | -149.505% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -99.257% |
| Talis Biomedical Corporation | -66.04 Million USD | 68.338% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -25.403% |
| Inogen, Inc. | -45.67 Million USD | 54.222% |
| Spectral AI, Inc. | -12.26 Million USD | -70.535% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 56.155% |
| CVRx, Inc. | -38.73 Million USD | 46.01% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -492.715% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -72.718% |
| Orthofix Medical Inc. | -86.98 Million USD | 75.96% |
| Venus Concept Inc. | -26.11 Million USD | 19.921% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 57.986% |
| Bioventus Inc. | -23.07 Million USD | 9.358% |
| BrainsWay Ltd. | -2.31 Million USD | -804.846% |
| Envoy Medical, Inc. | -18.23 Million USD | -14.656% |
| electroCore, Inc. | -17.76 Million USD | -17.742% |
| IceCure Medical Ltd | -15.25 Million USD | -37.094% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 57.969% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -24.059% |
| MaxCyte, Inc. | -44.12 Million USD | 52.613% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -77.875% |
| Nexalin Technology, Inc. | -5.69 Million USD | -267.373% |
| PAVmed Inc | -75.74 Million USD | 72.392% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 61.102% |
| RxSight, Inc. | -41.03 Million USD | 49.044% |
| Sight Sciences, Inc. | -49.41 Million USD | 57.683% |
| SI-BONE, Inc. | -34.44 Million USD | 39.293% |
| TELA Bio, Inc. | -40.63 Million USD | 48.537% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 64.131% |
| Treace Medical Concepts, Inc. | -39 Million USD | 46.393% |
| LivaNova PLC | 39.01 Million USD | 153.596% |
| 908 Devices Inc. | -34.02 Million USD | 38.542% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 81.092% |
| Nemaura Medical Inc. | -7.28 Million USD | -186.961% |
| NeuroPace, Inc. | -22.83 Million USD | 8.422% |
| LENSAR, Inc. | -8.71 Million USD | -139.97% |
| Apyx Medical Corporation | -18.11 Million USD | -15.454% |
| Cutera, Inc. | -136.56 Million USD | 84.687% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -518.669% |
| BioSig Technologies, Inc. | -28.15 Million USD | 25.718% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 931.121% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 0.372% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 105.452% |
| Axonics, Inc. | 7.77 Million USD | 368.952% |
| Outset Medical, Inc. | -153.78 Million USD | 86.403% |
| IRIDEX Corporation | -7.44 Million USD | -180.76% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 78.683% |
| IRadimed Corporation | 20.8 Million USD | 200.531% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -159.377% |
| INVO Bioscience, Inc. | -6.88 Million USD | -203.938% |
| Telesis Bio, Inc. | -40.49 Million USD | 48.359% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 157.014% |
| Varex Imaging Corporation | 67.2 Million USD | 131.118% |
| Quipt Home Medical Corp. | 44.07 Million USD | 147.448% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -92.374% |
| Pulmonx Corporation | -55.09 Million USD | 62.043% |
| Dynatronics Corporation | -976 Thousand USD | -2042.503% |
| Modular Medical, Inc. | -17.1 Million USD | -22.265% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -44.363% |
| Semler Scientific, Inc. | 23.58 Million USD | 188.647% |
| InMode Ltd. | 196.28 Million USD | 110.653% |
| Bruker Corporation | 599 Million USD | 103.491% |
| Cytosorbents Corporation | -28.81 Million USD | 27.42% |
| DexCom, Inc. | 916.7 Million USD | 102.281% |
| Align Technology, Inc. | 799.03 Million USD | 102.617% |
| Viveve Medical, Inc. | -20.61 Million USD | -1.426% |
| ZimVie Inc. | 91.07 Million USD | 122.961% |
| Movano Inc. | -29.12 Million USD | 28.203% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -374.388% |
| Nexalin Technology, Inc. | -5.69 Million USD | -267.373% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -492.715% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 89.258% |
| Profound Medical Corp. | -27.12 Million USD | 22.904% |
| Insulet Corporation | 323.6 Million USD | 106.462% |
| enVVeno Medical Corporation | -25.01 Million USD | 16.416% |
| Surmodics, Inc. | 1.18 Million USD | 1860.185% |
| iCAD, Inc. | -6.56 Million USD | -218.522% |
| Nuwellis, Inc. | -16.35 Million USD | -27.849% |
| Biotricity, Inc. | -8.82 Million USD | -136.864% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 78.412% |
| Aethlon Medical, Inc. | -11.84 Million USD | -76.477% |
| PAVmed Inc. | -75.74 Million USD | 72.392% |
| BIOLASE, Inc. | -15.13 Million USD | -38.127% |
| Beyond Air, Inc. | -59.03 Million USD | 64.576% |
| FONAR Corporation | 28.25 Million USD | 174.017% |
| AxoGen, Inc. | -13.32 Million USD | -56.895% |
| Vivani Medical, Inc. | -26.6 Million USD | 21.411% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 185.208% |
| Inari Medical, Inc. | 7.11 Million USD | 393.983% |
| UFP Technologies, Inc. | 72.74 Million USD | 128.746% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -517.611% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -239.685% |
| Tenon Medical, Inc. | -15.52 Million USD | -34.666% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -36.978% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 49.583% |
| AdaptHealth Corp. | -171.09 Million USD | 87.778% |
| Sintx Technologies, Inc. | -6.6 Million USD | -216.833% |
| NanoVibronix, Inc. | -3.43 Million USD | -508.763% |
| Quanterix Corporation | -38.08 Million USD | 45.098% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -92.374% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 69803.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 92.459% |
| TransMedics Group, Inc. | -7.6 Million USD | -175.036% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 3.924% |
| NeuroMetrix, Inc. | -7.09 Million USD | -194.695% |
| Hyperfine, Inc. | -47.06 Million USD | 55.566% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 64.136% |
| Biomerica, Inc. | -5.99 Million USD | -248.924% |
| Bone Biologics Corporation | 479.57 Thousand USD | 4460.346% |
| AVITA Medical, Inc. | -39.56 Million USD | 47.151% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -127.964% |
| Silk Road Medical, Inc | -45.08 Million USD | 53.614% |